Current small molecule process chemist at Eidos
-
Senior Director, Process Chemistry/CmcBridgebio Feb 2023 - PresentPalo Alto, California, Us -
Director, Drug SubstanceBridgebio Jan 2021 - PresentPalo Alto, California, Us -
Director, Drug SubstanceEidos Jan 2021 - Present
-
Associate DirectorEidos Feb 2019 - Jan 2021
-
Senior ScientistAchaogen May 2017 - Nov 2018South San Francisco, Ca, UsProcess Chemist for antibiotic drug development -
Scientist IiMedivation Mar 2016 - Mar 2017New York, Ny, UsProcess chemist -
Scientist IOnyx Pharmaceuticals, Inc., An Amgen Subsidiary 2012 - Dec 2015South San Francisco, Ca, UsProcess chemist -
Graduate Research AssistantBoston College Aug 2007 - May 2012Chestnut Hill, Ma, UsResearch Advisor: Professor James P. MorkenDevelopment of novel nickel-catalyzed 1,4-hydroboration and diboration of 1,3-dienes, to generate synthetically useful (Z)-allylic boronate esters, and application to the total synthesis of (+)-discodermolide.Publications:• Ely, R. J.; Yu, Z.; Morken, J. P. “Diastereoselective Ni-Catalyzed 1,4-Hydroboration of 1,3-Dieneols: Access to Synthetically Useful (Z)-Allyboronic Esters and Derived Polypropionate Motifs.” Tetrahedron Lett. 2015, 23, 3402. • Yu, Z; Ely, R. J.; Morken, J. P. “Synthesis of (+)-Discodermolide by Catalytic Stereoselective Borylation Reactions.” Angew. Chem. Int. Ed. 2014, 53, 9632.• Ely, R. J.; Morken, J. P. “Regio- and Stereoselective Ni-Catalyzed 1,4-Hydroboration of 1,3-Dienes: Access to Stereodefined (Z)-Allylboron Reagents and Derived Allylic Alcohols.” Org. Synth. 2011, 88, 342.• Ely, R. J.; Morken, J. P. “Ni(0)-Catalyzed 1,4-Selective Diboration of Conjugated Dienes.” Org. Lett. 2010, 12, 4348.• Ely, R. J.; Morken, J. P. “Regio- and Stereoselective Ni-Catalyzed 1,4-Hydroboration of 1,3-Dienes: Access to Stereodefined (Z)-Allylboron Reagents and Derived Allylic Alcohols.” J. Am. Chem. Soc. 2010, 132, 2534. -
Medicinal ChemistArray Biopharma May 2006 - Aug 2007Boulder, Co, UsMedicinal Chemist Intern: Synthesis of a variety of small molecule kinase inhibitors for drug discovery, scale-up of advanced intermediates.Publications:• Ren, L.; Wenglowsky, S.; Miknis, G.; Rast, B.; Buckmelter, A. J.; Ely, R. J.; Schlachter, S.; Laird, E. R.; Randolph, N.; Callejo, M.; Martinson, M.; Galbraith, S.; Brandhuber, B. J.; Vigers, G.; Morales, T.; Voegtli, W. C.; Lyssikatos, J. “Non-oxime inhibitors of B-RafV600E kinase.” Bioorg. Med. Chem. Lett. 2011, 21, 1243. -
University Of ColoradoChemical Engineering Department Aug 2005 - May 2006Research Advisor: Professor Christopher N. BowmanSynthesis of novel thiol-ene monomers for dental restorative material application.Publications:• Carioscia, J. A.; Schneidewind, L.; O’Brien, C.; Ely, R. J.; Feeser, C.; Cramer, N.; Bowman, C. N. “Thiol–Norbornene Materials: Approaches to Develop High Tg Thiol–Ene Polymers.” J. Poly. M. Sci. Part A: Polym. Chem. 2007, 45, 5686.
Robert Ely Education Details
-
Boston CollegeOrganic Chemistry -
University Of Colorado BoulderChemistry And Biochemistry
Frequently Asked Questions about Robert Ely
What company does Robert Ely work for?
Robert Ely works for Bridgebio
What is Robert Ely's role at the current company?
Robert Ely's current role is Senior Director, Process Chemistry/CMC.
What schools did Robert Ely attend?
Robert Ely attended Boston College, University Of Colorado Boulder.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial